Viewing Study NCT06742892

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 3:15 PM

Ignite Modification Date: 2025-12-24 @ 3:15 PM

Study NCT ID: NCT06742892

Status: RECRUITING

Last Update Posted: 2025-03-10

First Post: 2024-12-16

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy

Sponsor: Shanghai Henlius Biotech

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module